
July 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

July 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

July 23, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

July 23, 2019 Manufacturing and Production, Research and Development Crohn’s disease, Entyvio, Takeda, crohn's disease, pharma

July 23, 2019 Manufacturing and Production South East Asia, global health, infectious diseases, malaria, parasites

July 23, 2019 Manufacturing and Production, Sales and Marketing FDA, Lyrica, Pfizer, pharma

July 23, 2019 Manufacturing and Production acadia, clinical trials, menatl health, neuroscience, pharma, phase 3, schizophrenia

July 23, 2019 Manufacturing and Production Gilead, Novartis, antivrial, deal, herpes, influenza, rhinovirus

July 22, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, Contamination, FDA, India, chin, compliance, manufacturing, pharma, regulation, valsartan

July 19, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMAL Therapeutics, Alzheimer's Ebola, Amgen, AstraZeneca, EMA, FDA, Novartis, pharma

July 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

July 18, 2019 Manufacturing and Production, Medical Communications female representation, gender equality, pharma

July 17, 2019 Manufacturing and Production, Medical Communications, Research and Development Cancer, Kisqali, NICE, Novartis, UK, breast cancer, pharma

July 16, 2019 Manufacturing and Production, Sales and Marketing Bayer, FDA, Gadavist, coronary artery disease, pharma

July 16, 2019 Manufacturing and Production, Research and Development CAP-1002, Capricor Therapeutics, Duchenne Muscular Dystrophy, pharma